What is biorantee hormone substitution therapy?
Biorantee hormone substitution therapy, or BHRT, is a term used to describe the treatment of female menopause due to lack of estrogen and progesterone. Biojidentic hormone substitution therapy differs from conventional hormone substitution therapy (HRT) in that hormones are obtained from plants rather than horses. It should be noted, however, that both forms of therapy use a molecule similar to cholesterol obtained from plants called diosgenine to synthetic hormone production. In addition, both forms have the same molecular structure as hormones produced in the body. This is also the place where discussions about bioidential hormone substitution therapy are located. First, the latter supporters say that since the origin of the material comes from a natural source, that is, better absorption with less risk of unwanted side effects. In addition, biojidential hormone substitution therapy formulas are composed, which means they are made according to the unique physiology of a woman. On the other hand, conventionalHRT is considered to be a synthetic approach of universal everything with a history of related risks documented by several studies.
Burning the question has always been and continues to be: "Is the biorantee hormone substitution therapy more effective and safer than conventional hormone substitution therapy?" Unfortunately, there is no definitive answer due to several mitigating factors. Although it is true that there have been several European studies that indicate that bioidential hormone substitution therapy may be safer than HRT, it is also true that in the 25 years or more years of use there was no long -term studies. For American women, there is also a fact that many biojidential hormone substitution therapy of product are not approved by US food and drug management (FDA). In fact, the FDA does not even recognize the term "bioidentic", which is reflected in insufficient definition of regulatory and acceptable procedures concerningpreparation or administration.
On the other hand, this does not mean that bioidential hormone substitution therapy is no more dangerous than conventional HRT. In this respect, the FDA has approved several biomental hormones produced by pharmaceutical companies. It is a composite biomental hormones that FDA does not approve simply because adapted to combining a pharmacy for individual patients cannot be exposed to standardized procedures.
6 Therefore, it would be good to consult with a qualified practice that has experienced hormone therapy. This is the best way to make informed decisions and fully understand the risks associated with any hormonal therapy.